Mesa Laboratories (MLAB) News Today

Raymond James & Associates boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 8.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 80,739 shares of the medical instruments sup

Wells Fargo & Company began coverage on Mesa Laboratories in a report on Tuesday. They set an "underweight" rating and a $120.00 price objective on the stock.

Mesa Laboratories (NASDAQ:MLAB) Shares Gap Up to $128.90

Mesa Laboratories (NASDAQ:MLAB) Shares Gap Down to $130.82

Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 2.3%

Mesa Laboratories (NASDAQ:MLAB) Shares Pass Above Two Hundred Day Moving Average of $104.59

Evercore ISI increased their target price on shares of Mesa Laboratories from $106.00 to $120.00 and gave the company an "outperform" rating in a research report on Tuesday.

Motley Fool Asset Management LLC boosted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 89.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,488 shares of the medical instruments s

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced a quarterly dividend on Tuesday, July 9th. Investors of record on Friday, August 30th will be paid a dividend of 0.16 per share by the medical instruments supplier on Monday, September 16th. This represents a $0.64 annualized dividend and a yield of 0.69%. The ex-dividend date is Friday, August 30th.

Evercore ISI lowered their target price on Mesa Laboratories from $120.00 to $106.00 and set an "outperform" rating on the stock in a research report on Tuesday.

Boone Capital Management LLC bought a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 64,064 shares of the medical instruments supplier's stock, valued at approximately $6,712,000. Mesa

Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 5%

Mesa Laboratories (NASDAQ:MLAB) Trading 3.9% Higher

Principal Financial Group Inc. lessened its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 81.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,828 shares of the medical instrumen

Mesa Laboratories (NASDAQ:MLAB) Shares Gap Up to $110.36

Mesa Laboratories (NASDAQ:MLAB) Shares Down 5.5%

King Luther Capital Management Corp raised its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 100.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,781 shares of the medical

Mesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 156,000 shares, a decrease of 18.3% from the March 31st total of 191,000 shares. Based on an average trading volume of 44,200 shares, the short-interest ratio is presently 3.5 days.

Raymond James & Associates lessened its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 30.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 47,019 shares of the medical instruments suppl

Conestoga Capital Advisors LLC lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 9.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 578,463 shares of the medical instruments supplier's stock after purchasing an additional 48

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced a quarterly dividend on Thursday, April 4th. Stockholders of record on Friday, May 31st will be paid a dividend of 0.16 per share by the medical instruments supplier on Friday, June 14th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date of this dividend is Friday, May 31st.

Evercore ISI upped their price target on Mesa Laboratories from $124.00 to $130.00 and gave the stock an "outperform" rating in a research report on Thursday.

Mesa Laboratories (NASDAQ:MLAB) Stock Price Up 4.7%

Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 7.8%

Mesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 196,300 shares, a decline of 17.2% from the February 29th total of 237,200 shares. Based on an average daily trading volume, of 52,800 shares, the short-interest ratio is currently 3.7 days.

Comerica Bank bought a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 46,147 shares of the medical instruments

Mesa Laboratories (NASDAQ:MLAB) Shares Up 3.4%

Kennedy Capital Management LLC increased its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 42.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 109,496 shares of the medical instruments supp

Ranger Investment Management L.P. reduced its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 3.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 223,993 shares of the medical instruments supp